Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Definium Therapeutics Inc (DFTX)

242 + Investors. Track Smart Money conviction in DFTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +235
Streak
1Q ▲
Buyers last Q
98%

Smart Money Signals — DFTX

Based on 243 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 1Q
For 1 consecutive quarter, more hedge funds added DFTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
243 hedge funds hold DFTX right now — the highest count in 0.5 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🟢

More buyers than sellers — 98% buying

239 buying5 selling
Last quarter: 239 funds were net buyers (237 opened a brand new position + 2 added to an existing one). Only 5 were sellers (3 trimmed + 2 sold completely). A clear majority buying is a strong confirmation signal.
🔄

Mostly new holders — 100% entered in last year

■ 0% conviction (2yr+) ■ 0% medium ■ 100% new
Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +855% but shares only +575% — price-driven

Value
+855%
Shares
+574%
Last quarter: the total dollar value of institutional holdings rose +855%, but actual share count only changed +575%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🌱

Early stage — 100% of holders entered in last year

■ 0% veterans ■ 0% 1-2yr ■ 100% new
Of 253 current holders: 253 (100%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
✅

Strong quality — 25% AUM from major funds

25% from top-100 AUM funds
43 of 239 holders rank in the top 100 by AUM, accounting for 25% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
5.5
out of 10
Moderate Exit Risk
Exit risk score 5.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — DFTX

In 2026 Q1, 239 hedge funds were net buyers of DFTX (237 opened a new position, 2 added to an existing one), while 5 reduced or exited (3 trimmed, 2 sold completely) — a 98% buyer ratio, indicating clear institutional accumulation. 25% of total institutional value in DFTX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +235 funds (more new holders than closures). Total institutional holders: 243.

Hedge Fund Ownership: DFTX

How many hedge funds hold DFTX — quarterly history vs. share price
Quarterly hedge fund ownership of DFTX vs. share price

Market Analysis: DFTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: DFTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Definium Therapeutics Inc (DFTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much DFTX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
DFTX
+29.3%
XLV
+2.8%

DFTX outperformed XLV by +26.5% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
DFTX
+16.4%
XLV
+3.9%

Since the filing became public, DFTX outperformed XLV by +12.5% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

30 top-rated funds 5 high-conviction
Consensus
6.5
/ 10
breadth
×
Elite
3.9
/ 10
conviction
Hedge Fund Positioning: DFTX
242 + Investors

Track Smart Money conviction in DFTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 242 8 2925.0%
13F Shares 76M 11M 574.83%
Total Value $1.43B $150M 855.29%
New Positions 236 8 +228
Increased Positions 2 0 +2
Closed Positions 2 0 +2
Reduced Positions 3 0 +3
Total Calls 9 0 100%
Total Puts 5 0 100%
PUT/CALL Ratio 0.56 0.0 Bullish

Statistics: DFTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

242 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DFTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 DFTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Trails Edge Capital Partners, LP 7.53% 1,738,110 $32.9M
2 Octagon Capital Advisors LP 5.10% 2,440,000 $46.1M
3 Superstring Capital Management LP 4.75% 351,461 $6.6M
4 Catalio Capital Management, LP 4.10% 1,037,984 $19.6M
5 Data Collective IV GP, LLC 3.39% 100,350 $1.9M
6 AWM Investment Company, Inc. 2.25% 1,076,893 $20.4M
7 Commodore Capital LP 2.19% 2,000,000 $37.8M
8 Boxer Capital Management, LLC 1.49% 598,500 $11.3M
9 Soviero Asset Management, LP 1.32% 140,000 $2.6M
10 Stempoint Capital LP 1.20% 325,483 $6.2M
11 Patient Square Capital LP 1.11% 331,000 $6.3M
12 Tri Locum Partners LP 0.98% 369,588 $7.0M
13 HighVista Strategies LLC 0.97% 185,856 $3.5M
14 Rosalind Advisors, Inc. 0.95% 125,000 $2.4M
15 Avoro Capital Advisors LLC 0.93% 5,000,000 $94.5M
16 Deep Track Capital, LP 0.93% 3,000,000 $56.7M
17 Driehaus Capital Management LLC 0.82% 5,911,889 $111.7M
18 Silverback Asset Management LLC 0.81% 294,400 $5.6M
19 ArrowMark Colorado Holdings LLC 0.80% 1,594,717 $30.1M
20 Tetragon Partners GP Ltd 0.73% 199,994 $3.8M
21 Seven Fleet Capital Management LP 0.60% 99,887 $1.9M
22 Siren, L.L.C. 0.48% 919,493 $17.4M
23 PSP Research LLC 0.47% 34,800 $658K
24 Integral Health Asset Management, LLC 0.36% 400,000 $7.6M
25 PFM Health Sciences, LP 0.35% 205,317 $3.9M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Definium Therapeutics Inc (DFTX)

What does the Smart Money Trend signal show for DFTX?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added DFTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for DFTX?

More buyers than sellers — 98% buying: Last quarter: 239 funds were net buyers (237 opened a brand new position + 2 added to an existing one). Only 5 were sellers (3 trimmed + 2 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for DFTX holders?

Strong quality — 25% AUM from major funds: 43 of 239 holders rank in the top 100 by AUM, accounting for 25% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held DFTX?

Mostly new holders — 100% entered in last year: Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Definium Therapeutics Inc (DFTX) following the 2026 Q1 hedge fund 13F filings?

As of today, DFTX has moved +16.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of +12.5%. Since the quarter end (March 31, 2026), DFTX has gained +29.3% vs +2.8% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →